ATE405560T1 - Indolderivaten - Google Patents
IndolderivatenInfo
- Publication number
- ATE405560T1 ATE405560T1 AT03767555T AT03767555T ATE405560T1 AT E405560 T1 ATE405560 T1 AT E405560T1 AT 03767555 T AT03767555 T AT 03767555T AT 03767555 T AT03767555 T AT 03767555T AT E405560 T1 ATE405560 T1 AT E405560T1
- Authority
- AT
- Austria
- Prior art keywords
- indole derivatives
- indole
- derivatives
- Prior art date
Links
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical class C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 title 1
- 229940054051 antipsychotic indole derivative Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Emergency Medicine (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02026366 | 2002-11-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE405560T1 true ATE405560T1 (de) | 2008-09-15 |
Family
ID=32338000
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT03767555T ATE405560T1 (de) | 2002-11-25 | 2003-11-17 | Indolderivaten |
Country Status (21)
Country | Link |
---|---|
US (1) | US7098228B2 (de) |
EP (1) | EP1567523B1 (de) |
JP (1) | JP4384052B2 (de) |
KR (1) | KR100713266B1 (de) |
CN (1) | CN100343250C (de) |
AR (1) | AR042117A1 (de) |
AT (1) | ATE405560T1 (de) |
AU (1) | AU2003292030B2 (de) |
BR (1) | BR0316556A (de) |
CA (1) | CA2505545C (de) |
DE (1) | DE60323130D1 (de) |
ES (1) | ES2312819T3 (de) |
GT (1) | GT200300251A (de) |
MX (1) | MXPA05005445A (de) |
PA (1) | PA8589401A1 (de) |
PE (1) | PE20040843A1 (de) |
PL (1) | PL377320A1 (de) |
RU (1) | RU2315767C2 (de) |
TW (1) | TW200413357A (de) |
UY (1) | UY28091A1 (de) |
WO (1) | WO2004048371A1 (de) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050203151A1 (en) * | 2003-12-19 | 2005-09-15 | Kalypsys, Inc. | Novel compounds, compositions and uses thereof for treatment of metabolic disorders and related conditions |
ES2525229T3 (es) * | 2007-02-15 | 2014-12-19 | F. Hoffmann-La Roche Ag | 2-aminooxazolinas como ligandos de TAAR1 |
Family Cites Families (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4011326A (en) | 1975-07-29 | 1977-03-08 | Merck & Co., Inc. | 2-Substituted oxazolo[4,5-b]pyridine anti-inflammatory agents |
DE3034005C2 (de) | 1980-09-10 | 1982-12-09 | A. Nattermann & Cie GmbH, 5000 Köln | Indolessigsäure-Derivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zubereitungen |
CA1247547A (en) | 1983-06-22 | 1988-12-28 | Paul Hadvary | Leucine derivatives |
CA1328881C (en) | 1984-12-21 | 1994-04-26 | Pierre Barbier | Process for the manufacture of oxetanones |
CA1270837A (en) | 1984-12-21 | 1990-06-26 | Hoffmann-La Roche Limited | Oxetanones |
CA2035972C (en) | 1990-02-23 | 2006-07-11 | Martin Karpf | Process for the preparation of oxetanones |
US5089514A (en) | 1990-06-14 | 1992-02-18 | Pfizer Inc. | 3-coxazolyl [phenyl, chromanyl or benzofuranyl]-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents |
US5274143A (en) | 1991-07-23 | 1993-12-28 | Hoffmann-La Roche Inc. | Process for the preparation of (R)-3-hexyl-5,6-dihydro-4-hydroxy-6-undecyl-2H-pyran-2-one and (R)-5,6-dihydro-6-undecyl-2H-pyran-2,4(3H)-dione |
RU2134686C1 (ru) | 1992-07-03 | 1999-08-20 | Смитклайн Бичам П.Л.С. | Гетероциклическое соединение, или его таутомерная форма, и/или фармацевтически приемлемая соль, и/или фармацевтически приемлемый сольват, фармацевтическая композиция, снижающая содержание глюкозы в крови, способ лечения и/или профилактики гипергликемии |
GB9225386D0 (en) | 1992-12-04 | 1993-01-27 | Smithkline Beecham Plc | Novel compounds |
DE4317320A1 (de) | 1993-05-25 | 1994-12-01 | Boehringer Mannheim Gmbh | Neue Thiazolidindione und diese enthaltende Arzneimittel |
GB9326171D0 (en) | 1993-12-22 | 1994-02-23 | Smithkline Beecham Plc | Novel compounds |
JPH09176162A (ja) | 1995-12-22 | 1997-07-08 | Toubishi Yakuhin Kogyo Kk | チアゾリジンジオン誘導体及びその製造法並びにそれを含む医薬組成物 |
GB9600464D0 (en) | 1996-01-09 | 1996-03-13 | Smithkline Beecham Plc | Novel method |
DE69730837T2 (de) * | 1996-07-09 | 2005-09-29 | Nikem Research S.R.L., Baranzate Di Bollate | Indolderivate zur behandlung von osteoporose |
IL129999A (en) | 1996-12-10 | 2004-06-20 | Bristol Myers Squibb Co | Melatonergic agents which are benzodioxole, benzopuran, dihydrobenzopuran and benzodioxane |
US6004996A (en) | 1997-02-05 | 1999-12-21 | Hoffman-La Roche Inc. | Tetrahydrolipstatin containing compositions |
DE19711616A1 (de) | 1997-03-20 | 1998-09-24 | Boehringer Mannheim Gmbh | Verbessertes Verfahren zur Herstellung von Thiazolidindionen |
US6121397A (en) | 1997-07-14 | 2000-09-19 | Xerox Corporation | Polymerization processes using oligomeric compound, monomer and surfactant |
HN1998000118A (es) | 1997-08-27 | 1999-02-09 | Pfizer Prod Inc | 2 - aminopiridinas que contienen sustituyentes de anillos condensados. |
DE69815008T2 (de) | 1997-09-19 | 2004-04-01 | Ssp Co., Ltd. | Alfa-substituierte Phenylpropionsäurederivate und diese enthaltende Arzneimittel |
AU1120599A (en) | 1998-04-23 | 1999-03-08 | Dr. Reddy's Research Foundation | New heterocyclic compounds and their use in medicine, process for their reparation and pharmaceutical compositions containing them |
GB9817118D0 (en) | 1998-08-07 | 1998-10-07 | Glaxo Group Ltd | Pharmaceutical compounds |
PT1105122E (pt) | 1998-08-14 | 2005-08-31 | Hoffmann La Roche | Composicoes farmaceuticas que contem inibidores de lipase |
BR9912979B1 (pt) | 1998-08-14 | 2010-09-21 | composição farmacêutica administrável oralmente, tablete de mascar, cápsula e uso de chitosan. | |
GB9902459D0 (en) * | 1999-02-05 | 1999-03-24 | Zeneca Ltd | Chemical compounds |
GB9914977D0 (en) | 1999-06-25 | 1999-08-25 | Glaxo Group Ltd | Chemical compounds |
DE60026404T2 (de) | 1999-08-02 | 2006-10-19 | F. Hoffmann-La Roche Ag | Verfahren zur Herstellung von Benzothiophen-Derivaten |
CN1426303A (zh) * | 2000-01-19 | 2003-06-25 | 奥尔顿有限公司 | 噻唑、咪唑和噁唑化合物以及与蛋白老化相关疾病的治疗 |
PL360744A1 (en) | 2000-08-23 | 2004-09-20 | Eli Lilly And Company | Oxazolyl-arylpropionic acid derivatives and their use as ppar agonists |
US6949566B2 (en) * | 2000-09-29 | 2005-09-27 | Shionogi & Co. Ltd. | Thiazole and oxazole derivatives |
HU230224B1 (hu) * | 2001-05-15 | 2015-10-28 | F. Hoffmann-La Roche Ag | Karbonsavval helyettesített oxazol-származékok, PPAR-alfa- és -gamma-aktivátorként diabétesz kezelésére történő felhasználásra |
WO2003004458A1 (en) | 2001-07-03 | 2003-01-16 | Biovitrum Ab | New compounds |
TWI323658B (en) * | 2001-12-06 | 2010-04-21 | Nat Health Research Institutes | Novel compounds of indol-3-yl-2-oxyacetylamide derivatives, pharmaceutical composition thereof, and method for manufacturing the same |
US6933316B2 (en) * | 2001-12-13 | 2005-08-23 | National Health Research Institutes | Indole compounds |
WO2003053976A1 (en) | 2001-12-20 | 2003-07-03 | Biovitrum Ab | PIPAZOLO [1,5-a] PYRIMIDINE DERIVATIVES AS MODULATORS OF PPAR |
-
2003
- 2003-11-17 JP JP2004554364A patent/JP4384052B2/ja not_active Expired - Lifetime
- 2003-11-17 CA CA2505545A patent/CA2505545C/en not_active Expired - Fee Related
- 2003-11-17 EP EP03767555A patent/EP1567523B1/de not_active Expired - Lifetime
- 2003-11-17 DE DE60323130T patent/DE60323130D1/de not_active Expired - Lifetime
- 2003-11-17 CN CNB2003801041013A patent/CN100343250C/zh not_active Expired - Fee Related
- 2003-11-17 RU RU2005120152/04A patent/RU2315767C2/ru not_active IP Right Cessation
- 2003-11-17 ES ES03767555T patent/ES2312819T3/es not_active Expired - Lifetime
- 2003-11-17 PL PL377320A patent/PL377320A1/pl not_active Application Discontinuation
- 2003-11-17 AU AU2003292030A patent/AU2003292030B2/en not_active Ceased
- 2003-11-17 AT AT03767555T patent/ATE405560T1/de active
- 2003-11-17 KR KR1020057009337A patent/KR100713266B1/ko not_active IP Right Cessation
- 2003-11-17 BR BR0316556-6A patent/BR0316556A/pt not_active Withdrawn
- 2003-11-17 WO PCT/EP2003/012814 patent/WO2004048371A1/en active IP Right Grant
- 2003-11-17 MX MXPA05005445A patent/MXPA05005445A/es active IP Right Grant
- 2003-11-19 TW TW092132418A patent/TW200413357A/zh unknown
- 2003-11-21 AR ARP030104311A patent/AR042117A1/es not_active Application Discontinuation
- 2003-11-21 PE PE2003001184A patent/PE20040843A1/es not_active Application Discontinuation
- 2003-11-21 PA PA20038589401A patent/PA8589401A1/es unknown
- 2003-11-21 GT GT200300251A patent/GT200300251A/es unknown
- 2003-11-21 US US10/719,556 patent/US7098228B2/en not_active Expired - Fee Related
- 2003-11-24 UY UY28091A patent/UY28091A1/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2505545C (en) | 2011-06-07 |
PA8589401A1 (es) | 2004-07-20 |
DE60323130D1 (de) | 2008-10-02 |
AR042117A1 (es) | 2005-06-08 |
MXPA05005445A (es) | 2005-08-26 |
US7098228B2 (en) | 2006-08-29 |
JP4384052B2 (ja) | 2009-12-16 |
KR100713266B1 (ko) | 2007-05-04 |
CN1717407A (zh) | 2006-01-04 |
RU2315767C2 (ru) | 2008-01-27 |
TW200413357A (en) | 2004-08-01 |
WO2004048371A1 (en) | 2004-06-10 |
JP2006513173A (ja) | 2006-04-20 |
EP1567523A1 (de) | 2005-08-31 |
UY28091A1 (es) | 2004-05-31 |
GT200300251A (es) | 2004-06-28 |
US20040106657A1 (en) | 2004-06-03 |
AU2003292030A1 (en) | 2004-06-18 |
EP1567523B1 (de) | 2008-08-20 |
CA2505545A1 (en) | 2004-06-10 |
KR20050086759A (ko) | 2005-08-30 |
PL377320A1 (pl) | 2006-01-23 |
CN100343250C (zh) | 2007-10-17 |
PE20040843A1 (es) | 2004-12-24 |
BR0316556A (pt) | 2005-10-04 |
RU2005120152A (ru) | 2006-05-27 |
AU2003292030B2 (en) | 2007-01-04 |
ES2312819T3 (es) | 2009-03-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60336314D1 (de) | Substituierte indole | |
DK1490355T3 (da) | Indolylmaleimidderivater | |
ATE478870T1 (de) | Spiroindolinpiperidinderivate | |
ATE460418T1 (de) | Heterocyclocarboxamidderivate | |
DK1551802T3 (da) | Indol-3-svovlderivater | |
ATE467631T1 (de) | Chinuclidinamidderivate | |
IS7720A (is) | Píperidín-N-oxíð-afleiður | |
ATE438644T1 (de) | Chinazolinderivate | |
DK2248807T3 (da) | N-Phenyl-2-pyrimidinaminderivater | |
IS7667A (is) | Nýjar bensimídazólafleiður | |
ATE340782T1 (de) | Piperidinbenzolsulfonamidderivate | |
DK1682493T3 (da) | Amidoacetonitrilderivater | |
ATE352550T1 (de) | Chinazolinderivate | |
ATE386518T1 (de) | Benzimidazolderivate | |
ATE395345T1 (de) | Imidazol-4-yl-ethynyl-pyridin-derivate | |
DE60307512D1 (de) | 3h-chinazoline -4-on derivaten | |
ATE354365T1 (de) | N-thiazol-2-yl-benzamid-derivate | |
ATE423771T1 (de) | Tetrahydrochinolinderivate | |
ATE457299T1 (de) | 4-hydroxymethyl-1-aryl-cyclohexylamin-derivativ | |
DK1706373T3 (da) | Amidoacetonitrilderivater | |
DE50306277D1 (de) | 4-alkyl-/4-alkenyl-/4-alkinylmethyl/-1-arylcyclohexylamin-derivate | |
IS2431B (is) | Nýjar indólafleiður | |
IS7906A (is) | Afleiður própargýl-tríflúorómetoxý-amínó-benzóþíazóls | |
DE60323130D1 (de) | Indolderivaten | |
DK1503988T3 (da) | Fredericamycin-derivater |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1567523 Country of ref document: EP |